Close Menu

NEW YORK (GenomeWeb) – Using a Quidel Sofia influenza immunoassay as an initial screening tool saved Tufts Medical Center approximately $36,000 during the 2014 winter flu season, researchers at the center have reported.

In a retrospective analysis of a respiratory illness testing algorithm using the Quidel assay prior to syndromic testing with the BioFire FilmArray respiratory panel, clinicians and laboratorians at Tufts said the $36,000 was saved in comparison to a summer period in which the 20-target FilmArray panel test was used alone as the first-line assay.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

A federal judge has ruled that drug companies, device manufacturers, and universities need to provide missing clinical data from hundreds of trials to a federal website, ScienceInsider reports.

A genetic analysis suggests red pandas might actually belong to two different species, New Scientist reports.

NPR reports that the US Centers for Disease Control and Prevention has fixed the problem with some of its SARS-CoV-2 testing kits.

In Nature this week: epigenetic factors that prevent healthy aging and more.